STOCK TITAN

Ajay Dhankhar Joins Lazard as a Managing Director in Healthcare Group, Financial Advisory

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Lazard Ltd (NYSE: LAZ) has appointed Ajay Dhankhar as Managing Director in the Healthcare Group of Financial Advisory, effective immediately. Mr. Dhankhar will act as Global Head of Medical Technology, Diagnostics, and Tools, advising clients in biopharmaceuticals and healthcare technology. With over 50 major transactions under his belt, he join from McKinsey & Company, enhancing Lazard's advisory capabilities in a growing healthcare sector.

Positive
  • Ajay Dhankhar's extensive experience strengthens Lazard's expertise in the healthcare sector.
  • His leadership is expected to enhance client advisory in medical technology and diagnostics.
Negative
  • None.

NEW YORK--(BUSINESS WIRE)-- Lazard Ltd (NYSE: LAZ) announced today that Ajay Dhankhar has joined the firm as a Managing Director in the Healthcare Group within Financial Advisory, effective immediately. Based in New York, Mr. Dhankhar will serve as Global Head of Medical Technology, Diagnostics and Tools. He will also advise clients in other healthcare segments, including biopharmaceuticals, and healthcare information and technology.

“Ajay brings deep experience to our Healthcare practice as a trusted strategic advisor to C-suite executives and boards,” said David Gluckman, Global Head of the Healthcare Group at Lazard. “The healthcare sector, including medical devices and technology, is experiencing strong growth that is set to continue in the years ahead. Adding a seasoned healthcare advisor like Ajay will ensure Lazard continues to provide clients with the very best possible advice.”

Mr. Dhankhar is a former biochemist and a highly experienced healthcare advisor, with particular expertise in the fields of medical technology, diagnostics and tools, and biopharmaceuticals. He is an established thought leader, espousing the concept that portfolio optimization through M&A, joint ventures and divestments, when coupled with rational capital allocation, can help companies deliver sector- and industry-leading shareholder value.

Mr. Dhankhar has advised on more than 50 major transactions, including four of the 10 largest mergers and/or restructurings to have taken place in the life sciences industry in recent years. He joins Lazard from McKinsey & Company, where he was a Senior Partner and Global Leader of the firm’s Life Sciences Strategy, M&A, Corporate Finance and Enterprise Risk practices. He previously served as Global Leader of McKinsey’s Life Sciences R&D practice.

Mr. Dhankhar has a bachelor’s degree in Physics and Computer Science from Angelo State University and both a master’s degree and a doctorate in Molecular Biophysics and Biochemistry from Yale University.

About Lazard
Lazard, one of the world's preeminent financial advisory and asset management firms, operates from 40 cities across 25 countries in North and South America, Europe, Asia and Australia. With origins dating to 1848, the firm provides advice on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments and individuals. For more information on Lazard, please visit www.lazard.com. Follow Lazard at @Lazard

LAZ_FAPE 

Media Contact:

Judi Frost Mackey, +1 212 632 1428

judi.mackey@lazard.com

Investor Contact:

Alexandra Deignan, +1 212 632 6886

alexandra.deignan@lazard.com

Source: Lazard Ltd

FAQ

Who is Ajay Dhankhar and what role has he taken at Lazard?

Ajay Dhankhar has joined Lazard as Managing Director in the Healthcare Group, serving as Global Head of Medical Technology, Diagnostics, and Tools.

What experience does Ajay Dhankhar bring to Lazard?

Ajay Dhankhar has advised on over 50 major transactions in the healthcare sector and previously served as Senior Partner at McKinsey & Company.

How will Ajay Dhankhar's role impact Lazard stock (LAZ)?

Dhankhar's extensive expertise is expected to strengthen Lazard's advisory capabilities, potentially enhancing client relationships and financial performance.

What sectors will Ajay Dhankhar focus on at Lazard?

He will focus on medical technology, diagnostics, biopharmaceuticals, and healthcare information and technology.

When did Ajay Dhankhar start his position at Lazard?

Ajay Dhankhar's appointment as Managing Director at Lazard is effective immediately.

Lazard, Inc.

NYSE:LAZ

LAZ Rankings

LAZ Latest News

LAZ Stock Data

5.22B
109.41M
2.92%
71.3%
2.87%
Capital Markets
Investment Advice
Link
United States of America
NEW YORK